Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Testando a adição de radioterapia estereotáxica com imunoterapia para o tratamento de pacientes com câncer de células renais metastático ou irressecável, estudo SAMURAI (SAMURAI)

21 de outubro de 2026 atualizado por: NRG Oncology

Radioterapia ablativa estereotáxica randomizada de fase II (SABR) para carcinoma de células renais metastático não ressecado (RCC) recebendo imunoterapia (SAMURAI)

This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread from where it first started (primary site) to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Descrição detalhada

PRIMARY OBJECTIVE:

I. To determine whether the addition of stereotactic ablative radiotherapy (SABR) to the primary tumor in combination with immunotherapy improves outcomes compared to immunotherapy alone in patients with metastatic, unresected, renal cell carcinoma (RCC). The primary endpoint is nephrectomy and radiographic progression-free survival (nrPFS) with progression determined as per iRECIST criteria.

SECONDARY OBJECTIVES:

I. To assess the safety, toxicity and tolerability of the two treatment strategies as defined by Common Terminology Criteria for Adverse Events (CTCAE) version 5 in each treatment arm.

II. To assess the objective response rate (ORR) by Immune-related Response Evaluation Criteria in Solid Tumors (iRECIST) in each treatment arm.

III. Nephrectomy and radiographic progression-free survival excluding nephrectomies that were performed for non-protocol specified indications (nephrectomy and radiographic progression-free survival [nrPFS]2).

IV. Radiographic progression-free survival (rPFS). V. To assess overall survival (OS) in each treatment arm. VI. To assess the time to subsequent second-line therapy or death in each treatment arm.

VII. To assess the rate of cytoreductive nephrectomy in each treatment arm. VIII. To assess treatment-free survival in patients who discontinue therapy for reason other than radiographic disease progression.

IX. To assess the ORR by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 and iRECIST in the primary renal mass.

EXPLORATORY OBJECTIVES:

I. To assess composite nrPFS in the predefined histological subgroups below:

Ia. Clear cell versus non-clear cell histology; Ib. International Metastatic RCC database consortium (IMDC) intermediate versus poor risk group; Ic. Systemic treatment with immunotherapy-immunotherapy combination versus immunotherapy-vascular endothelial growth factor (VEGF) targeted therapy combination; Id. Sarcomatoid versus non sarcomatoid variant. II. To identify prognostic and predictive biomarkers of response to SABR in the context of immunotherapy based treatment via assessment of tissue and blood based biomarkers.

III. To evaluate the abscopal effect of SABR with systemic therapy. IIIa. Compare ORR in non-irradiated target lesions in the control arm patients undergoing immunotherapy alone to the experimental arm undergoing SABR + immunotherapy.

IV. To evaluate the impact of treatment on level of inferior vena cava (IVC) thrombus.

V. To compare accruing center identified iRECIST progression and centrally identified iRECIST progression events on computed tomography (CT).

OUTLINE: Patients are randomized to 1 of 2 arms. Patients are randomized in a 2:1 ratio favoring the SABR arm.

ARM I: Patients receive one of the following immunotherapy regimens per physician discretion: nivolumab intravenously (IV) over 30 minutes and ipilimumab IV over 30 minutes every 3 weeks for 4 doses followed by nivolumab IV over 30 minutes every 2 or 4 weeks; pembrolizumab IV over 30 minutes every 3 or 6 weeks and axitinib orally (PO) twice daily (BID); avelumab IV over 60 minutes every 2 weeks and axitinib PO BID; nivolumab IV over 30 minutes every 2 or 4 weeks and cabozantinib PO once daily (QD); OR pembrolizumab IV over 30 minutes every 3 or 6 weeks and lenvatinib PO QD. Treatment with immunotherapy continues in the absence of disease progression or unacceptable toxicity. Patients also undergo computed tomography (CT) scan or magnetic resonance imaging (MRI) throughout the trial. Patients may also undergo a bone scan as clinically indicated and blood sample collection throughout the trial.

ARM II: Patients undergo SABR on 3 different days over 1-3 weeks and receive immunotherapy as in Arm I. Patients also undergo CT scan or MRI throughout the trial. Patients may also undergo a bone scan as clinically indicated and blood sample collection throughout the trial.

After completion of study treatment, patients are followed up every 6 months for 5 years, and then annually for 3 years.

Tipo de estudo

Intervencional

Inscrição (Estimado)

240

Estágio

  • Fase 2

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Victoria
      • Melbourne, Victoria, Austrália, 3000
        • Suspenso
        • Peter MacCallum Cancer Centre
    • Ontario
      • Toronto, Ontario, Canadá, M5G 2M9
        • Suspenso
        • University Health Network-Princess Margaret Hospital
    • Quebec
      • Québec, Quebec, Canadá, G1R 2J6
        • Suspenso
        • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
    • Alabama
      • Birmingham, Alabama, Estados Unidos, 35233
        • Ativo, não recrutando
        • University of Alabama at Birmingham Cancer Center
    • Arizona
      • Kingman, Arizona, Estados Unidos, 86401
        • Suspenso
        • Kingman Regional Medical Center
      • Phoenix, Arizona, Estados Unidos, 85054
        • Recrutamento
        • Mayo Clinic Hospital in Arizona
        • Contato:
          • Site Public Contact
          • Número de telefone: 855-776-0015
        • Investigador principal:
          • Mark Waddle
    • Arkansas
      • Fayetteville, Arkansas, Estados Unidos, 72703
        • Recrutamento
        • Highlands Oncology Group - Fayetteville
        • Investigador principal:
          • Joseph T. Beck
        • Contato:
      • Little Rock, Arkansas, Estados Unidos, 72205
        • Recrutamento
        • University of Arkansas for Medical Sciences
        • Contato:
          • Site Public Contact
          • Número de telefone: 501-686-8274
        • Investigador principal:
          • Sanjay Maraboyina
      • Rogers, Arkansas, Estados Unidos, 72758
        • Recrutamento
        • Highlands Oncology Group - Rogers
        • Investigador principal:
          • Joseph T. Beck
        • Contato:
      • Springdale, Arkansas, Estados Unidos, 72762
        • Recrutamento
        • Highlands Oncology Group
        • Investigador principal:
          • Joseph T. Beck
        • Contato:
    • California
      • Arroyo Grande, California, Estados Unidos, 93420
        • Suspenso
        • PCR Oncology
      • Beverly Hills, California, Estados Unidos, 90211
      • Burlingame, California, Estados Unidos, 94010
      • Duarte, California, Estados Unidos, 91010
        • Ativo, não recrutando
        • City of Hope Comprehensive Cancer Center
      • Encinitas, California, Estados Unidos, 92024
        • Recrutamento
        • UC San Diego Health System - Encinitas
        • Investigador principal:
          • Tyler M. Seibert
        • Contato:
          • Site Public Contact
          • Número de telefone: 760-536-7700
      • Irvine, California, Estados Unidos, 92612
        • Recrutamento
        • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-827-8839
          • E-mail: ucstudy@uci.edu
        • Investigador principal:
          • Shera Feinstein
      • La Jolla, California, Estados Unidos, 92093
        • Recrutamento
        • UC San Diego Moores Cancer Center
        • Investigador principal:
          • Tyler M. Seibert
        • Contato:
      • Los Angeles, California, Estados Unidos, 90048
        • Recrutamento
        • Cedars-Sinai Medical Center
        • Investigador principal:
          • Leslie Ballas
        • Contato:
      • Los Angeles, California, Estados Unidos, 90033
        • Recrutamento
        • USC / Norris Comprehensive Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 323-865-0451
        • Investigador principal:
          • Lauren A. Lukas
      • Los Angeles, California, Estados Unidos, 90025
        • Recrutamento
        • The Angeles Clinic and Research Institute - West Los Angeles Office
        • Investigador principal:
          • Leslie Ballas
        • Contato:
      • Los Angeles, California, Estados Unidos, 90033
        • Recrutamento
        • Los Angeles General Medical Center
        • Contato:
        • Investigador principal:
          • Lauren A. Lukas
      • Modesto, California, Estados Unidos, 95355
      • Orange, California, Estados Unidos, 92868
        • Recrutamento
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-827-8839
          • E-mail: ucstudy@uci.edu
        • Investigador principal:
          • Shera Feinstein
      • Roseville, California, Estados Unidos, 95661
        • Recrutamento
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
        • Investigador principal:
          • Christopher U. Jones
        • Contato:
      • Roseville, California, Estados Unidos, 95661
      • Sacramento, California, Estados Unidos, 95816
      • San Diego, California, Estados Unidos, 92103
        • Recrutamento
        • UC San Diego Medical Center - Hillcrest
        • Investigador principal:
          • Tyler M. Seibert
        • Contato:
      • San Francisco, California, Estados Unidos, 94158
        • Recrutamento
        • UCSF Medical Center-Mission Bay
        • Investigador principal:
          • Steven N. Seyedin
        • Contato:
      • San Luis Obispo, California, Estados Unidos, 93401
        • Ativo, não recrutando
        • Pacific Central Coast Health Center-San Luis Obispo
      • San Mateo, California, Estados Unidos, 94401
      • Santa Barbara, California, Estados Unidos, 93105
      • Santa Rosa, California, Estados Unidos, 95403
        • Recrutamento
        • Sutter Pacific Medical Foundation
        • Investigador principal:
          • Christopher U. Jones
        • Contato:
    • Colorado
      • Aurora, Colorado, Estados Unidos, 80045
        • Recrutamento
        • UCHealth University of Colorado Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 720-848-0650
        • Investigador principal:
          • Corbin Eule
      • Denver, Colorado, Estados Unidos, 80206
        • Recrutamento
        • UCHealth - Cherry Creek
        • Contato:
        • Investigador principal:
          • Corbin Eule
      • Fort Collins, Colorado, Estados Unidos, 80524
        • Recrutamento
        • Poudre Valley Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 970-297-6150
        • Investigador principal:
          • Corbin Eule
      • Fort Collins, Colorado, Estados Unidos, 80528
        • Recrutamento
        • Cancer Care and Hematology-Fort Collins
        • Contato:
        • Investigador principal:
          • Corbin Eule
      • Greeley, Colorado, Estados Unidos, 80631
        • Recrutamento
        • UCHealth Greeley Hospital
        • Contato:
        • Investigador principal:
          • Corbin Eule
      • Highlands Ranch, Colorado, Estados Unidos, 80129
        • Recrutamento
        • UCHealth Highlands Ranch Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 720-848-0650
        • Investigador principal:
          • Corbin Eule
      • Lone Tree, Colorado, Estados Unidos, 80124
        • Recrutamento
        • UCHealth Lone Tree Health Center
        • Contato:
        • Investigador principal:
          • Corbin Eule
      • Loveland, Colorado, Estados Unidos, 80538
        • Recrutamento
        • Medical Center of the Rockies
        • Contato:
          • Site Public Contact
          • Número de telefone: 970-203-7083
        • Investigador principal:
          • Corbin Eule
    • Delaware
      • Lewes, Delaware, Estados Unidos, 19958
        • Recrutamento
        • Beebe Medical Center
        • Contato:
        • Investigador principal:
          • Gregory A. Masters
      • Millville, Delaware, Estados Unidos, 19967
        • Recrutamento
        • Beebe South Coastal Health Campus
        • Contato:
        • Investigador principal:
          • Gregory A. Masters
      • Newark, Delaware, Estados Unidos, 19713
        • Recrutamento
        • Helen F Graham Cancer Center
        • Investigador principal:
          • Gregory A. Masters
        • Contato:
      • Newark, Delaware, Estados Unidos, 19713
        • Recrutamento
        • Medical Oncology Hematology Consultants PA
        • Investigador principal:
          • Gregory A. Masters
        • Contato:
      • Newark, Delaware, Estados Unidos, 19718
        • Recrutamento
        • Christiana Care Health System-Christiana Hospital
        • Investigador principal:
          • Gregory A. Masters
        • Contato:
      • Rehoboth Beach, Delaware, Estados Unidos, 19971
        • Recrutamento
        • Beebe Health Campus
        • Contato:
        • Investigador principal:
          • Gregory A. Masters
      • Wilmington, Delaware, Estados Unidos, 19801
        • Recrutamento
        • Christiana Care Health System-Wilmington Hospital
        • Investigador principal:
          • Gregory A. Masters
        • Contato:
    • Florida
      • Aventura, Florida, Estados Unidos, 33180
        • Recrutamento
        • Mount Sinai Comprehensive Cancer Center at Aventura
        • Contato:
        • Investigador principal:
          • Debra L. Linzer
      • Hollywood, Florida, Estados Unidos, 33021
        • Recrutamento
        • Memorial Regional Hospital/Joe DiMaggio Children's Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 954-265-1847
          • E-mail: OHR@mhs.net
        • Investigador principal:
          • Brian A. Pico
      • Jacksonville, Florida, Estados Unidos, 32224-9980
        • Recrutamento
        • Mayo Clinic in Florida
        • Contato:
          • Site Public Contact
          • Número de telefone: 855-776-0015
        • Investigador principal:
          • Mark Waddle
      • Land O' Lakes, Florida, Estados Unidos, 34638
        • Recrutamento
        • Moffitt Cancer Center at Speros
        • Contato:
        • Investigador principal:
          • Kareem Rayn
      • Miami, Florida, Estados Unidos, 33176
        • Recrutamento
        • Miami Cancer Institute
        • Investigador principal:
          • Adeel Kaiser
        • Contato:
          • Site Public Contact
          • Número de telefone: 786-596-2000
      • Miami Beach, Florida, Estados Unidos, 33140
        • Recrutamento
        • Mount Sinai Medical Center
        • Investigador principal:
          • Debra L. Linzer
        • Contato:
      • Pembroke Pines, Florida, Estados Unidos, 33028
        • Recrutamento
        • Memorial Hospital West
        • Contato:
          • Site Public Contact
          • Número de telefone: 954-265-4325
        • Investigador principal:
          • Brian A. Pico
      • Ruskin, Florida, Estados Unidos, 33570
        • Recrutamento
        • Moffitt Cancer Center at SouthShore
        • Contato:
        • Investigador principal:
          • Kareem Rayn
      • Tampa, Florida, Estados Unidos, 33607
        • Recrutamento
        • Moffitt Cancer Center-International Plaza
        • Contato:
        • Investigador principal:
          • Kareem Rayn
      • Tampa, Florida, Estados Unidos, 33612
        • Recrutamento
        • Moffitt Cancer Center - McKinley Campus
        • Contato:
        • Investigador principal:
          • Kareem Rayn
      • Tampa, Florida, Estados Unidos, 33612
        • Recrutamento
        • Moffitt Cancer Center
        • Contato:
        • Investigador principal:
          • Kareem Rayn
      • Wesley Chapel, Florida, Estados Unidos, 33544
        • Recrutamento
        • Moffitt Cancer Center at Wesley Chapel
        • Contato:
        • Investigador principal:
          • Kareem Rayn
    • Idaho
      • Boise, Idaho, Estados Unidos, 83706
        • Recrutamento
        • Saint Alphonsus Cancer Care Center-Boise
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Caldwell, Idaho, Estados Unidos, 83605
        • Recrutamento
        • Saint Alphonsus Cancer Care Center-Caldwell
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Nampa, Idaho, Estados Unidos, 83687
        • Recrutamento
        • Saint Alphonsus Cancer Care Center-Nampa
        • Contato:
        • Investigador principal:
          • Samir Narayan
    • Illinois
      • Alton, Illinois, Estados Unidos, 62002
        • Recrutamento
        • Alton Memorial Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 618-463-7323
        • Investigador principal:
          • Hiram A. Gay
      • Centralia, Illinois, Estados Unidos, 62801
        • Recrutamento
        • Centralia Oncology Clinic
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Chicago, Illinois, Estados Unidos, 60637
        • Recrutamento
        • University of Chicago Comprehensive Cancer Center
        • Contato:
        • Investigador principal:
          • Stanley L. Liauw
      • Chicago, Illinois, Estados Unidos, 60611
        • Recrutamento
        • Northwestern University
        • Contato:
        • Investigador principal:
          • Sean Sachdev
      • Chicago, Illinois, Estados Unidos, 60641
        • Recrutamento
        • Northwestern Medicine Cancer Center Old Irving Park
        • Investigador principal:
          • Sean Sachdev
        • Contato:
      • Danville, Illinois, Estados Unidos, 61832
        • Recrutamento
        • Carle at The Riverfront
        • Investigador principal:
          • Daniel H. Barnett
        • Contato:
      • DeKalb, Illinois, Estados Unidos, 60115
        • Recrutamento
        • Northwestern Medicine Cancer Center Kishwaukee
        • Contato:
        • Investigador principal:
          • Sean Sachdev
      • Decatur, Illinois, Estados Unidos, 62526
        • Recrutamento
        • Cancer Care Specialists of Illinois - Decatur
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Decatur, Illinois, Estados Unidos, 62526
        • Recrutamento
        • Decatur Memorial Hospital
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Effingham, Illinois, Estados Unidos, 62401
        • Recrutamento
        • Carle Physician Group-Effingham
        • Investigador principal:
          • Daniel H. Barnett
        • Contato:
      • Effingham, Illinois, Estados Unidos, 62401
        • Recrutamento
        • Crossroads Cancer Center
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Geneva, Illinois, Estados Unidos, 60134
        • Recrutamento
        • Northwestern Medicine Cancer Center Delnor
        • Contato:
        • Investigador principal:
          • Sean Sachdev
      • Glenview, Illinois, Estados Unidos, 60026
        • Recrutamento
        • Northwestern Medicine Glenview Outpatient Center
        • Investigador principal:
          • Sean Sachdev
        • Contato:
          • Site Public Contact
          • Número de telefone: 312-695-1102
      • Grayslake, Illinois, Estados Unidos, 60030
        • Recrutamento
        • Northwestern Medicine Grayslake Outpatient Center
        • Investigador principal:
          • Sean Sachdev
        • Contato:
          • Site Public Contact
          • Número de telefone: 312-695-1102
      • Harvey, Illinois, Estados Unidos, 60426
        • Recrutamento
        • Ingalls Memorial Hospital
        • Investigador principal:
          • James A. Wallace
        • Contato:
      • Lake Forest, Illinois, Estados Unidos, 60045
        • Recrutamento
        • Northwestern Medicine Lake Forest Hospital
        • Contato:
        • Investigador principal:
          • Sean Sachdev
      • Mattoon, Illinois, Estados Unidos, 61938
        • Recrutamento
        • Carle Physician Group-Mattoon/Charleston
        • Investigador principal:
          • Daniel H. Barnett
        • Contato:
      • New Lenox, Illinois, Estados Unidos, 60451
        • Recrutamento
        • UC Comprehensive Cancer Center at Silver Cross
        • Contato:
        • Investigador principal:
          • Stanley L. Liauw
      • O'Fallon, Illinois, Estados Unidos, 62269
        • Recrutamento
        • Cancer Care Center of O'Fallon
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • O'Fallon, Illinois, Estados Unidos, 62269
        • Recrutamento
        • HSHS Saint Elizabeth's Hospital
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Oak Brook, Illinois, Estados Unidos, 60523
      • Orland Park, Illinois, Estados Unidos, 60462
        • Recrutamento
        • University of Chicago Medicine-Orland Park
        • Contato:
        • Investigador principal:
          • Stanley L. Liauw
      • Orland Park, Illinois, Estados Unidos, 60462
      • Rockford, Illinois, Estados Unidos, 61114
        • Recrutamento
        • UW Health Carbone Cancer Center Rockford
        • Contato:
        • Investigador principal:
          • Fahrettin Covut
      • Shiloh, Illinois, Estados Unidos, 62269
        • Recrutamento
        • Memorial Hospital East
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
      • Springfield, Illinois, Estados Unidos, 62702
        • Recrutamento
        • Southern Illinois University School of Medicine
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
          • Site Public Contact
          • Número de telefone: 217-545-7929
      • Springfield, Illinois, Estados Unidos, 62702
        • Recrutamento
        • Springfield Clinic
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-444-7541
      • Springfield, Illinois, Estados Unidos, 62781
        • Recrutamento
        • Springfield Memorial Hospital
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
      • Urbana, Illinois, Estados Unidos, 61801
        • Recrutamento
        • Carle Cancer Center
        • Investigador principal:
          • Daniel H. Barnett
        • Contato:
      • Urbana, Illinois, Estados Unidos, 61801
        • Recrutamento
        • The Carle Foundation Hospital
        • Investigador principal:
          • Daniel H. Barnett
        • Contato:
      • Warrenville, Illinois, Estados Unidos, 60555
        • Recrutamento
        • Northwestern Medicine Cancer Center Warrenville
        • Contato:
        • Investigador principal:
          • Sean Sachdev
    • Indiana
      • Crown Point, Indiana, Estados Unidos, 46307
        • Recrutamento
        • UChicago Medicine Northwest Indiana
        • Investigador principal:
          • Stanley L. Liauw
        • Contato:
      • Indianapolis, Indiana, Estados Unidos, 46237
        • Recrutamento
        • Franciscan Health Indianapolis
        • Contato:
          • Site Public Contact
          • Número de telefone: 317-528-7060
        • Investigador principal:
          • Craig Schneider
      • Mooresville, Indiana, Estados Unidos, 46158
        • Recrutamento
        • Franciscan Health Mooresville
        • Contato:
          • Site Public Contact
          • Número de telefone: 317-834-3603
        • Investigador principal:
          • Craig Schneider
    • Iowa
      • Ames, Iowa, Estados Unidos, 50010
        • Recrutamento
        • Mary Greeley Medical Center
        • Investigador principal:
          • Joseph J. Merchant
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-956-4132
      • Ames, Iowa, Estados Unidos, 50010
        • Recrutamento
        • McFarland Clinic - Ames
        • Investigador principal:
          • Joseph J. Merchant
        • Contato:
      • Ankeny, Iowa, Estados Unidos, 50023
        • Recrutamento
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-3305
        • Investigador principal:
          • Seema Harichand-Herdt
      • Clive, Iowa, Estados Unidos, 50325
        • Recrutamento
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-3305
        • Investigador principal:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Estados Unidos, 50309
        • Recrutamento
        • Iowa Methodist Medical Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-6727
        • Investigador principal:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Estados Unidos, 50309
        • Recrutamento
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-3305
        • Investigador principal:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Estados Unidos, 50314
        • Recrutamento
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-3305
        • Investigador principal:
          • Seema Harichand-Herdt
      • Waukee, Iowa, Estados Unidos, 50263
        • Recrutamento
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Contato:
          • Site Public Contact
          • Número de telefone: 515-241-3305
        • Investigador principal:
          • Seema Harichand-Herdt
    • Louisiana
      • Baton Rouge, Louisiana, Estados Unidos, 70809
        • Recrutamento
        • Louisiana Hematology Oncology Associates LLC
        • Contato:
        • Investigador principal:
          • Victor T. Lin
      • Baton Rouge, Louisiana, Estados Unidos, 70809
        • Recrutamento
        • Mary Bird Perkins Cancer Center
        • Contato:
        • Investigador principal:
          • Victor T. Lin
      • Metairie, Louisiana, Estados Unidos, 70006
        • Ativo, não recrutando
        • East Jefferson General Hospital
      • Metairie, Louisiana, Estados Unidos, 70006
        • Ativo, não recrutando
        • LSU Healthcare Network / Metairie Multi-Specialty Clinic
      • Metairie, Louisiana, Estados Unidos, 70002
        • Recrutamento
        • Mary Bird Perkins Cancer Center - Metairie
        • Investigador principal:
          • Victor T. Lin
        • Contato:
          • Site Public Contact
          • Número de telefone: 504-584-6990
      • New Orleans, Louisiana, Estados Unidos, 70112
        • Ativo, não recrutando
        • Louisiana State University Health Science Center
      • New Orleans, Louisiana, Estados Unidos, 70112
        • Ativo, não recrutando
        • University Medical Center New Orleans
      • New Orleans, Louisiana, Estados Unidos, 70115
        • Ativo, não recrutando
        • Touro Infirmary
    • Maine
      • Bath, Maine, Estados Unidos, 04530
        • Ativo, não recrutando
        • MaineHealth Coastal Cancer Treatment Center
      • Biddeford, Maine, Estados Unidos, 04005
        • Ativo, não recrutando
        • MaineHealth Maine Medical Center - Biddeford
      • Portland, Maine, Estados Unidos, 04102
        • Ativo, não recrutando
        • MaineHealth Maine Medical Center - Portland
      • Sanford, Maine, Estados Unidos, 04073
        • Ativo, não recrutando
        • MaineHealth Cancer Care Center of York County
      • Sanford, Maine, Estados Unidos, 04073
        • Ativo, não recrutando
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, Estados Unidos, 04074
        • Ativo, não recrutando
        • MaineHealth Maine Medical Center- Scarborough
      • South Portland, Maine, Estados Unidos, 04106
        • Ativo, não recrutando
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21201
        • Ativo, não recrutando
        • University of Maryland/Greenebaum Cancer Center
      • Columbia, Maryland, Estados Unidos, 21044
        • Ativo, não recrutando
        • Central Maryland Radiation Oncology in Howard County
      • Glen Burnie, Maryland, Estados Unidos, 21061
        • Ativo, não recrutando
        • UM Baltimore Washington Medical Center/Tate Cancer Center
    • Massachusetts
      • Beverly, Massachusetts, Estados Unidos, 01915
        • Ativo, não recrutando
        • Beverly Hospital
      • Boston, Massachusetts, Estados Unidos, 02115
        • Recrutamento
        • Brigham and Women's Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 617-724-5200
        • Investigador principal:
          • Bradley A. McGregor
      • Boston, Massachusetts, Estados Unidos, 02114
        • Recrutamento
        • Massachusetts General Hospital Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-726-5130
        • Investigador principal:
          • Sophia C. Kamran
      • Boston, Massachusetts, Estados Unidos, 02215
        • Recrutamento
        • Dana-Farber Cancer Institute
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-442-3324
        • Investigador principal:
          • Bradley A. McGregor
      • Burlington, Massachusetts, Estados Unidos, 01805
        • Ativo, não recrutando
        • Lahey Clinic
      • Gloucester, Massachusetts, Estados Unidos, 01930
        • Ativo, não recrutando
        • Addison Gilbert Hospital
      • Peabody, Massachusetts, Estados Unidos, 01960
        • Ativo, não recrutando
        • Lahey Clinic Peabody
      • Winchester, Massachusetts, Estados Unidos, 01890
        • Ativo, não recrutando
        • Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48109
        • Recrutamento
        • University of Michigan Rogel Cancer Center
        • Investigador principal:
          • William C. Jackson
        • Contato:
      • Ann Arbor, Michigan, Estados Unidos, 48106
        • Recrutamento
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Brighton, Michigan, Estados Unidos, 48114
        • Recrutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Brighton, Michigan, Estados Unidos, 48114
        • Recrutamento
        • Trinity Health Medical Center - Brighton
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Canton, Michigan, Estados Unidos, 48188
        • Recrutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Canton, Michigan, Estados Unidos, 48188
        • Recrutamento
        • Trinity Health Medical Center - Canton
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Chelsea, Michigan, Estados Unidos, 48118
        • Recrutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Chelsea, Michigan, Estados Unidos, 48118
      • Dearborn, Michigan, Estados Unidos, 48124
        • Recrutamento
        • Corewell Health Dearborn Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 248-551-7695
        • Investigador principal:
          • Daniel J. Krauss
      • Farmington Hills, Michigan, Estados Unidos, 48336
        • Suspenso
        • Corewell Health Farmington Hills Hospital
      • Lansing, Michigan, Estados Unidos, 48912
        • Recrutamento
        • University of Michigan Health - Sparrow Lansing
        • Investigador principal:
          • Samir Narayan
        • Contato:
      • Livonia, Michigan, Estados Unidos, 48154
        • Recrutamento
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Royal Oak, Michigan, Estados Unidos, 48073
        • Recrutamento
        • Corewell Health William Beaumont University Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 248-551-7695
        • Investigador principal:
          • Daniel J. Krauss
      • Troy, Michigan, Estados Unidos, 48085
        • Recrutamento
        • Corewell Health Beaumont Troy Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 248-551-7695
        • Investigador principal:
          • Daniel J. Krauss
      • Ypsilanti, Michigan, Estados Unidos, 48197
        • Recrutamento
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Contato:
        • Investigador principal:
          • Samir Narayan
    • Minnesota
      • Bemidji, Minnesota, Estados Unidos, 56601
      • Brainerd, Minnesota, Estados Unidos, 56401
        • Recrutamento
        • Essentia Health Saint Joseph's Medical Center
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Chaska, Minnesota, Estados Unidos, 55318
        • Recrutamento
        • Minnesota Oncology Hematology PA-Chaska
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Coon Rapids, Minnesota, Estados Unidos, 55433
        • Recrutamento
        • Mercy Hospital
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Deer River, Minnesota, Estados Unidos, 56636
        • Recrutamento
        • Essentia Health - Deer River Clinic
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Duluth, Minnesota, Estados Unidos, 55805
        • Recrutamento
        • Essentia Health Cancer Center
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Duluth, Minnesota, Estados Unidos, 55805
        • Recrutamento
        • Essentia Health Saint Mary's Medical Center
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Duluth, Minnesota, Estados Unidos, 55805
        • Recrutamento
        • Miller-Dwan Hospital
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Edina, Minnesota, Estados Unidos, 55435
        • Recrutamento
        • Fairview Southdale Hospital
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Hibbing, Minnesota, Estados Unidos, 55746
        • Recrutamento
        • Essentia Health Hibbing Clinic
        • Investigador principal:
          • Bret E. Friday
        • Contato:
          • Site Public Contact
          • Número de telefone: 218-786-3308
      • Maple Grove, Minnesota, Estados Unidos, 55369
        • Recrutamento
        • Fairview Clinics and Surgery Center Maple Grove
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Minneapolis, Minnesota, Estados Unidos, 55407
        • Recrutamento
        • Abbott-Northwestern Hospital
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Minneapolis, Minnesota, Estados Unidos, 55415
        • Recrutamento
        • Hennepin County Medical Center
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Minneapolis, Minnesota, Estados Unidos, 55455
        • Recrutamento
        • University of Minnesota/Masonic Cancer Center
        • Investigador principal:
          • Ian J. Okazaki
        • Contato:
          • Site Public Contact
          • Número de telefone: 612-624-2620
      • Rochester, Minnesota, Estados Unidos, 55905
        • Recrutamento
        • Mayo Clinic in Rochester
        • Contato:
          • Site Public Contact
          • Número de telefone: 855-776-0015
        • Investigador principal:
          • Mark Waddle
      • Saint Louis Park, Minnesota, Estados Unidos, 55416
        • Recrutamento
        • Park Nicollet Clinic - Saint Louis Park
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Saint Paul, Minnesota, Estados Unidos, 55101
        • Recrutamento
        • Regions Hospital
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Sandstone, Minnesota, Estados Unidos, 55072
        • Recrutamento
        • Essentia Health Sandstone
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Shakopee, Minnesota, Estados Unidos, 55379
        • Recrutamento
        • Saint Francis Regional Medical Center
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Stillwater, Minnesota, Estados Unidos, 55082
        • Recrutamento
        • Lakeview Hospital
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Virginia, Minnesota, Estados Unidos, 55792
        • Recrutamento
        • Essentia Health Virginia Clinic
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Waconia, Minnesota, Estados Unidos, 55387
        • Recrutamento
        • Ridgeview Medical Center
        • Contato:
        • Investigador principal:
          • Charles Shideman
    • Missouri
      • Cape Girardeau, Missouri, Estados Unidos, 63703
        • Recrutamento
        • Saint Francis Medical Center
        • Investigador principal:
          • Bryan A. Faller
        • Contato:
          • Site Public Contact
          • Número de telefone: 573-334-2230
          • E-mail: sfmc@sfmc.net
      • City of Saint Peters, Missouri, Estados Unidos, 63376
        • Recrutamento
        • Siteman Cancer Center at Saint Peters Hospital
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
      • Columbia, Missouri, Estados Unidos, 65212
        • Recrutamento
        • MU Health - University Hospital/Ellis Fischel Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 573-882-7440
        • Investigador principal:
          • Gregory B. Biedermann
      • Creve Coeur, Missouri, Estados Unidos, 63141
        • Recrutamento
        • Siteman Cancer Center at West County Hospital
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
      • Springfield, Missouri, Estados Unidos, 65804
        • Recrutamento
        • Mercy Hospital Springfield
        • Investigador principal:
          • Jay W. Carlson
        • Contato:
          • Site Public Contact
          • Número de telefone: 417-269-4520
      • St Louis, Missouri, Estados Unidos, 63110
        • Recrutamento
        • Washington University School of Medicine
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
      • St Louis, Missouri, Estados Unidos, 63128
        • Recrutamento
        • Mercy Hospital South
        • Investigador principal:
          • Jay W. Carlson
        • Contato:
      • St Louis, Missouri, Estados Unidos, 63141
        • Recrutamento
        • Mercy Hospital Saint Louis
        • Investigador principal:
          • Jay W. Carlson
        • Contato:
          • Site Public Contact
          • Número de telefone: 314-251-7066
      • St Louis, Missouri, Estados Unidos, 63129
        • Recrutamento
        • Siteman Cancer Center-South County
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
      • St Louis, Missouri, Estados Unidos, 63136
        • Recrutamento
        • Siteman Cancer Center at Christian Hospital
        • Contato:
        • Investigador principal:
          • Hiram A. Gay
    • Nebraska
      • Bellevue, Nebraska, Estados Unidos, 68123
        • Recrutamento
        • Nebraska Medicine-Bellevue
        • Contato:
          • Site Public Contact
          • Número de telefone: 402-559-6941
          • E-mail: unmcrsa@unmc.edu
        • Investigador principal:
          • Harshraj Leuva
      • Omaha, Nebraska, Estados Unidos, 68198
        • Recrutamento
        • University of Nebraska Medical Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 402-559-6941
          • E-mail: unmcrsa@unmc.edu
        • Investigador principal:
          • Harshraj Leuva
      • Omaha, Nebraska, Estados Unidos, 68118
        • Recrutamento
        • Nebraska Medicine-Village Pointe
        • Contato:
          • Site Public Contact
          • Número de telefone: 402-559-5600
        • Investigador principal:
          • Harshraj Leuva
    • Nevada
      • Reno, Nevada, Estados Unidos, 89502
        • Recrutamento
        • Renown Regional Medical Center
        • Contato:
        • Investigador principal:
          • Suchit H. Patel
    • New Jersey
      • Basking Ridge, New Jersey, Estados Unidos, 07920
        • Recrutamento
        • Memorial Sloan Kettering Basking Ridge
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • Camden, New Jersey, Estados Unidos, 08103
        • Recrutamento
        • Cooper Hospital University Medical Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 856-325-6757
        • Investigador principal:
          • Gary Eastwick
      • Lakewood, New Jersey, Estados Unidos, 08701
        • Ativo, não recrutando
        • Monmouth Medical Center Southern Campus
      • Long Branch, New Jersey, Estados Unidos, 07740
        • Ativo, não recrutando
        • Monmouth Medical Center
      • Middletown, New Jersey, Estados Unidos, 07748
        • Recrutamento
        • Memorial Sloan Kettering Monmouth
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • Montvale, New Jersey, Estados Unidos, 07645
        • Recrutamento
        • Memorial Sloan Kettering Bergen
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • Mount Laurel, New Jersey, Estados Unidos, 08054
        • Recrutamento
        • Cooper CyberKnife Center
        • Investigador principal:
          • Gary Eastwick
        • Contato:
      • New Brunswick, New Jersey, Estados Unidos, 08903
        • Ativo, não recrutando
        • Rutgers Cancer Institute of New Jersey
      • Newark, New Jersey, Estados Unidos, 07101
        • Ativo, não recrutando
        • Rutgers New Jersey Medical School
      • Toms River, New Jersey, Estados Unidos, 08755
        • Ativo, não recrutando
        • Community Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Estados Unidos, 87102
        • Recrutamento
        • Lovelace Medical Center-Saint Joseph Square
        • Investigador principal:
          • Thomas M. Schroeder
        • Contato:
      • Albuquerque, New Mexico, Estados Unidos, 87109
        • Recrutamento
        • Lovelace Radiation Oncology
        • Contato:
          • Site Public Contact
          • Número de telefone: 505-272-0530
          • E-mail: AYost@nmcca.org
        • Investigador principal:
          • Thomas M. Schroeder
      • Albuquerque, New Mexico, Estados Unidos, 87106
        • Recrutamento
        • University of New Mexico Cancer Center
        • Contato:
        • Investigador principal:
          • Thomas M. Schroeder
    • New York
      • Bay Shore, New York, Estados Unidos, 11706
        • Recrutamento
        • Northwell Health Imbert Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 516-734-8896
        • Investigador principal:
          • Clary Evans
      • Commack, New York, Estados Unidos, 11725
        • Recrutamento
        • Memorial Sloan Kettering Commack
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • Glens Falls, New York, Estados Unidos, 12801
        • Recrutamento
        • Glens Falls Hospital
        • Investigador principal:
          • Nataniel H. Lester-Coll
        • Contato:
          • Site Public Contact
          • Número de telefone: 518-926-6700
      • Greenlawn, New York, Estados Unidos, 11740
        • Recrutamento
        • Northwell Health Cancer Institute at Huntington
        • Contato:
          • Site Public Contact
          • Número de telefone: 516-734-8896
        • Investigador principal:
          • Clary Evans
      • Harrison, New York, Estados Unidos, 10604
        • Recrutamento
        • Memorial Sloan Kettering Westchester
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • Lake Success, New York, Estados Unidos, 11042
        • Recrutamento
        • Northwell Health/Center for Advanced Medicine
        • Contato:
          • Site Public Contact
          • Número de telefone: 516-734-8896
        • Investigador principal:
          • Clary Evans
      • Mount Kisco, New York, Estados Unidos, 10549
        • Recrutamento
        • Northern Westchester Hospital
        • Contato:
        • Investigador principal:
          • Clary Evans
      • New York, New York, Estados Unidos, 10065
        • Recrutamento
        • Memorial Sloan Kettering Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
      • New York, New York, Estados Unidos, 10016
        • Recrutamento
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • Investigador principal:
          • Anand Mahadevan
        • Contato:
      • New York, New York, Estados Unidos, 10075
        • Recrutamento
        • Lenox Hill Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 516-734-8896
        • Investigador principal:
          • Clary Evans
      • New York, New York, Estados Unidos, 10065
        • Recrutamento
        • Manhattan Eye Ear and Throat Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-434-4460
        • Investigador principal:
          • Clary Evans
      • Sleepy Hollow, New York, Estados Unidos, 10591
        • Recrutamento
        • Phelps Memorial Hospital Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 914-366-1600
        • Investigador principal:
          • Clary Evans
      • Stony Brook, New York, Estados Unidos, 11794
        • Ativo, não recrutando
        • Stony Brook University Medical Center
      • Uniondale, New York, Estados Unidos, 11553
        • Recrutamento
        • Memorial Sloan Kettering Nassau
        • Contato:
          • Site Public Contact
          • Número de telefone: 212-639-7592
        • Investigador principal:
          • Daniel Gorovets
    • North Carolina
      • Cary, North Carolina, Estados Unidos, 27518
        • Recrutamento
        • Duke Cancer Center Cary
        • Investigador principal:
          • Ryan E. Fecteau
        • Contato:
      • Chapel Hill, North Carolina, Estados Unidos, 27599
        • Recrutamento
        • UNC Lineberger Comprehensive Cancer Center
        • Contato:
        • Investigador principal:
          • Tracy L. Rose
      • Charlotte, North Carolina, Estados Unidos, 28203
        • Recrutamento
        • Carolinas Medical Center/Levine Cancer Institute
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-804-9376
        • Investigador principal:
          • Claud M. Grigg
      • Charlotte, North Carolina, Estados Unidos, 28210
        • Recrutamento
        • Atrium Health Pineville/LCI-Pineville
        • Contato:
          • Site Public Contact
          • Número de telefone: 980-442-2000
        • Investigador principal:
          • Claud M. Grigg
      • Charlotte, North Carolina, Estados Unidos, 28262
        • Recrutamento
        • Atrium Health University City/LCI-University
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-804-9376
        • Investigador principal:
          • Claud M. Grigg
      • Charlotte, North Carolina, Estados Unidos, 28277
        • Recrutamento
        • Levine Cancer Institute-Ballantyne
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-804-9376
        • Investigador principal:
          • Claud M. Grigg
      • Clemmons, North Carolina, Estados Unidos, 27012
        • Recrutamento
        • Wake Forest University at Clemmons
        • Contato:
          • Site Public Contact
          • Número de telefone: 888-716-9259
        • Investigador principal:
          • Michael McCormack
      • Concord, North Carolina, Estados Unidos, 28025
        • Recrutamento
        • Atrium Health Cabarrus/LCI-Concord
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-804-9376
        • Investigador principal:
          • Claud M. Grigg
      • Durham, North Carolina, Estados Unidos, 27710
        • Recrutamento
        • Duke University Medical Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 888-275-3853
        • Investigador principal:
          • Ryan E. Fecteau
      • Gastonia, North Carolina, Estados Unidos, 28054
        • Recrutamento
        • Levine Cancer Institute-Gaston
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-804-9376
        • Investigador principal:
          • Claud M. Grigg
      • High Point, North Carolina, Estados Unidos, 27262
        • Recrutamento
        • Hayworth Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 336-802-2500
        • Investigador principal:
          • Michael McCormack
      • Monroe, North Carolina, Estados Unidos, 28112
        • Recrutamento
        • Atrium Health Union/LCI-Union
        • Contato:
          • Site Public Contact
          • Número de telefone: 980-442-2000
        • Investigador principal:
          • Claud M. Grigg
      • Raleigh, North Carolina, Estados Unidos, 27609
        • Recrutamento
        • Duke Cancer Center Raleigh
        • Investigador principal:
          • Ryan E. Fecteau
        • Contato:
      • Statesville, North Carolina, Estados Unidos, 28677
        • Recrutamento
        • Wake Forest Baptist Health - Hematology Oncology - Statesville
        • Contato:
          • Site Public Contact
          • Número de telefone: 704-872-3630
        • Investigador principal:
          • Michael McCormack
      • Wilkesboro, North Carolina, Estados Unidos, 28659
        • Recrutamento
        • Wake Forest Baptist Health - Wilkes Medical Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 888-716-9253
        • Investigador principal:
          • Michael McCormack
      • Winston-Salem, North Carolina, Estados Unidos, 27157
        • Recrutamento
        • Wake Forest University Health Sciences
        • Contato:
          • Site Public Contact
          • Número de telefone: 336-713-6771
        • Investigador principal:
          • Michael McCormack
    • North Dakota
      • Bismarck, North Dakota, Estados Unidos, 58501
      • Fargo, North Dakota, Estados Unidos, 58122
      • Fargo, North Dakota, Estados Unidos, 58122
    • Ohio
      • Avon, Ohio, Estados Unidos, 44011
        • Recrutamento
        • UH Seidman Cancer Center at UH Avon Health Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 800-641-2422
        • Investigador principal:
          • Pedro Barata
      • Beachwood, Ohio, Estados Unidos, 44122
        • Recrutamento
        • UHHS-Chagrin Highlands Medical Center
        • Contato:
        • Investigador principal:
          • Pedro Barata
      • Centerville, Ohio, Estados Unidos, 45459
        • Recrutamento
        • Miami Valley Hospital South
        • Contato:
        • Investigador principal:
          • Tarek M. Sabagh
      • Centerville, Ohio, Estados Unidos, 45459
        • Ativo, não recrutando
        • Dayton Physicians LLC-Miami Valley South
      • Cincinnati, Ohio, Estados Unidos, 45219
        • Recrutamento
        • University of Cincinnati Cancer Center-UC Medical Center
        • Investigador principal:
          • Timothy D. Struve
        • Contato:
      • Cleveland, Ohio, Estados Unidos, 44106
        • Recrutamento
        • Case Western Reserve University
        • Contato:
        • Investigador principal:
          • Pedro Barata
      • Columbus, Ohio, Estados Unidos, 43210
        • Recrutamento
        • Ohio State University Comprehensive Cancer Center
        • Contato:
        • Investigador principal:
          • Shang-Jui Wang
      • Dayton, Ohio, Estados Unidos, 45409
        • Recrutamento
        • Miami Valley Hospital
        • Contato:
        • Investigador principal:
          • Tarek M. Sabagh
      • Dayton, Ohio, Estados Unidos, 45415
        • Recrutamento
        • Miami Valley Hospital North
        • Contato:
        • Investigador principal:
          • Tarek M. Sabagh
      • Dayton, Ohio, Estados Unidos, 45409
        • Recrutamento
        • Premier Blood and Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 937-276-8320
        • Investigador principal:
          • Tarek M. Sabagh
      • Dayton, Ohio, Estados Unidos, 45415
        • Ativo, não recrutando
        • Dayton Physician LLC - Englewood
      • Franklin, Ohio, Estados Unidos, 45005-1066
        • Recrutamento
        • Atrium Medical Center-Middletown Regional Hospital
        • Contato:
        • Investigador principal:
          • Tarek M. Sabagh
      • Franklin, Ohio, Estados Unidos, 45005
        • Ativo, não recrutando
        • Dayton Physicians LLC-Atrium
      • Greenville, Ohio, Estados Unidos, 45331
        • Recrutamento
        • Miami Valley Cancer Care and Infusion
        • Investigador principal:
          • Tarek M. Sabagh
        • Contato:
          • Site Public Contact
          • Número de telefone: 937-569-7515
      • Mentor, Ohio, Estados Unidos, 44060
        • Recrutamento
        • UH Seidman Cancer Center at Lake Health Mentor Campus
        • Contato:
        • Investigador principal:
          • Pedro Barata
      • Parma, Ohio, Estados Unidos, 44129
        • Recrutamento
        • University Hospitals Parma Medical Center
        • Contato:
        • Investigador principal:
          • Pedro Barata
      • Ravenna, Ohio, Estados Unidos, 44266
        • Recrutamento
        • University Hospitals Portage Medical Center
        • Contato:
        • Investigador principal:
          • Pedro Barata
      • Troy, Ohio, Estados Unidos, 45373
        • Recrutamento
        • Upper Valley Medical Center
        • Contato:
        • Investigador principal:
          • Tarek M. Sabagh
      • West Chester, Ohio, Estados Unidos, 45069
        • Recrutamento
        • University of Cincinnati Cancer Center-West Chester
        • Investigador principal:
          • Timothy D. Struve
        • Contato:
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • Recrutamento
        • University of Oklahoma Health Sciences Center
        • Contato:
        • Investigador principal:
          • Tyler Gunter
      • Tulsa, Oklahoma, Estados Unidos, 74146
        • Recrutamento
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
        • Contato:
          • Site Public Contact
          • Número de telefone: 918-505-3200
        • Investigador principal:
          • Mark B. Jennings
    • Pennsylvania
      • Allentown, Pennsylvania, Estados Unidos, 18103
        • Recrutamento
        • Lehigh Valley Hospital-Cedar Crest
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Beaver, Pennsylvania, Estados Unidos, 15009
        • Recrutamento
        • UPMC-Heritage Valley Health System Beaver
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-389-5208
          • E-mail: haneydl@upmc.edu
        • Investigador principal:
          • Adam Olson
      • Bethlehem, Pennsylvania, Estados Unidos, 18017
        • Recrutamento
        • Lehigh Valley Hospital - Muhlenberg
        • Contato:
        • Investigador principal:
          • Samir Narayan
      • Carlisle, Pennsylvania, Estados Unidos, 17015
        • Recrutamento
        • Carlisle Regional Cancer Center
        • Contato:
        • Investigador principal:
          • Adam Olson
      • Chadds Ford, Pennsylvania, Estados Unidos, 19317
        • Recrutamento
        • Christiana Care Health System-Concord Health Center
        • Investigador principal:
          • Gregory A. Masters
        • Contato:
      • Danville, Pennsylvania, Estados Unidos, 17822
        • Recrutamento
        • Geisinger Medical Center
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Dickson City, Pennsylvania, Estados Unidos, 18519
        • Recrutamento
        • Geisinger Cancer Center Dickson City
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Erie, Pennsylvania, Estados Unidos, 16505
        • Recrutamento
        • UPMC Hillman Cancer Center Erie
        • Investigador principal:
          • Adam Olson
        • Contato:
      • Erie, Pennsylvania, Estados Unidos, 16544
        • Recrutamento
        • Saint Vincent Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 814-452-5000
        • Investigador principal:
          • Alexander Helfand
      • Farrell, Pennsylvania, Estados Unidos, 16121
        • Recrutamento
        • UPMC Cancer Center at UPMC Horizon
        • Contato:
        • Investigador principal:
          • Adam Olson
      • Greensburg, Pennsylvania, Estados Unidos, 15601
        • Recrutamento
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Contato:
          • Site Public Contact
          • Número de telefone: 724-838-1900
        • Investigador principal:
          • Adam Olson
      • Harrisburg, Pennsylvania, Estados Unidos, 17109
        • Recrutamento
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
        • Contato:
        • Investigador principal:
          • Adam Olson
      • Hazleton, Pennsylvania, Estados Unidos, 18201
        • Recrutamento
        • Geisinger Medical Center-Cancer Center Hazleton
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Hershey, Pennsylvania, Estados Unidos, 17033-0850
        • Recrutamento
        • Penn State Milton S Hershey Medical Center
        • Investigador principal:
          • Joseph A. Miccio
        • Contato:
          • Site Public Contact
          • Número de telefone: 717-531-3779
          • E-mail: CTO@hmc.psu.edu
      • Indiana, Pennsylvania, Estados Unidos, 15701
        • Recrutamento
        • IRMC Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-389-5208
          • E-mail: haneydl@upmc.edu
        • Investigador principal:
          • Adam Olson
      • Jefferson Hills, Pennsylvania, Estados Unidos, 15025
        • Recrutamento
        • Jefferson Hospital
        • Contato:
        • Investigador principal:
          • Alexander Helfand
      • Lewisburg, Pennsylvania, Estados Unidos, 17837
        • Recrutamento
        • Geisinger Medical Oncology-Lewisburg
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Mechanicsburg, Pennsylvania, Estados Unidos, 17050
        • Recrutamento
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-389-5208
          • E-mail: haneydl@upmc.edu
        • Investigador principal:
          • Adam Olson
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • Recrutamento
        • Forbes Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-858-7746
        • Investigador principal:
          • Alexander Helfand
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • Recrutamento
        • UPMC Hillman Cancer Center - Monroeville
        • Investigador principal:
          • Adam Olson
        • Contato:
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • Recrutamento
        • UPMC Cancer Center - Monroeville
        • Contato:
        • Investigador principal:
          • Adam Olson
      • New Castle, Pennsylvania, Estados Unidos, 16105
        • Recrutamento
        • UPMC Hillman Cancer Center - New Castle
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-389-5208
          • E-mail: haneydl@upmc.edu
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15213
        • Recrutamento
        • UPMC-Magee Womens Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-647-2811
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15224
        • Recrutamento
        • West Penn Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-578-5000
        • Investigador principal:
          • Alexander Helfand
      • Pittsburgh, Pennsylvania, Estados Unidos, 15215
        • Recrutamento
        • UPMC-Saint Margaret
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-784-4900
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15237
        • Recrutamento
        • UPMC-Passavant Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-367-6454
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15243
        • Recrutamento
        • UPMC-Saint Clair Hospital Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-502-3920
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15212
        • Recrutamento
        • Allegheny General Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-284-2000
        • Investigador principal:
          • Alexander Helfand
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • Recrutamento
        • UPMC Hillman Cancer Center
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-647-8073
        • Investigador principal:
          • Adam Olson
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • Recrutamento
        • UPMC-Shadyside Hospital
        • Investigador principal:
          • Adam Olson
        • Contato:
          • Site Public Contact
          • Número de telefone: 412-621-2334
      • Pottsville, Pennsylvania, Estados Unidos, 17901
        • Recrutamento
        • Geisinger Cancer Services-Pottsville
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Scranton, Pennsylvania, Estados Unidos, 18510
        • Recrutamento
        • Community Medical Center
        • Investigador principal:
          • Fiori Alite
        • Contato:
      • Seneca, Pennsylvania, Estados Unidos, 16346
        • Recrutamento
        • UPMC Cancer Center at UPMC Northwest
        • Contato:
          • Site Public Contact
          • Número de telefone: 814-676-7900
        • Investigador principal:
          • Adam Olson
      • Washington, Pennsylvania, Estados Unidos, 15301
        • Recrutamento
        • UPMC Cancer Center-Washington
        • Contato:
        • Investigador principal:
          • Adam Olson
      • Washington, Pennsylvania, Estados Unidos, 15301
        • Recrutamento
        • UPMC Washington Hospital Radiation Oncology
        • Contato:
        • Investigador principal:
          • Adam Olson
      • West Reading, Pennsylvania, Estados Unidos, 19611
        • Recrutamento
        • Reading Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 610-988-9323
        • Investigador principal:
          • Michael L. Haas
      • Wexford, Pennsylvania, Estados Unidos, 15090
        • Recrutamento
        • Wexford Health and Wellness Pavilion
        • Contato:
        • Investigador principal:
          • Alexander Helfand
      • Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
        • Recrutamento
        • Geisinger Wyoming Valley/Henry Cancer Center
        • Contato:
        • Investigador principal:
          • Fiori Alite
      • Williamsport, Pennsylvania, Estados Unidos, 17754
        • Recrutamento
        • Divine Providence Hospital
        • Contato:
        • Investigador principal:
          • Adam Olson
      • York, Pennsylvania, Estados Unidos, 17408
        • Recrutamento
        • UPMC Memorial
        • Contato:
          • Site Public Contact
          • Número de telefone: 717-724-6760
        • Investigador principal:
          • Adam Olson
    • South Carolina
      • Charleston, South Carolina, Estados Unidos, 29425
        • Recrutamento
        • Medical University of South Carolina
        • Contato:
        • Investigador principal:
          • Harriet B. Eldredge-Hindy
      • Greenwood, South Carolina, Estados Unidos, 29646
        • Recrutamento
        • Self Regional Healthcare
        • Contato:
        • Investigador principal:
          • Harriet B. Eldredge-Hindy
    • South Dakota
      • Sioux Falls, South Dakota, Estados Unidos, 57104
        • Recrutamento
        • Sanford Cancer Center Oncology Clinic
        • Investigador principal:
          • Daniel Almquist
        • Contato:
      • Sioux Falls, South Dakota, Estados Unidos, 57117-5134
    • Texas
      • Dallas, Texas, Estados Unidos, 75390
        • Recrutamento
        • UT Southwestern/Simmons Cancer Center-Dallas
        • Contato:
        • Investigador principal:
          • Raquibul Hannan
      • Dallas, Texas, Estados Unidos, 75235
        • Recrutamento
        • Parkland Memorial Hospital
        • Contato:
        • Investigador principal:
          • Raquibul Hannan
      • Dallas, Texas, Estados Unidos, 75237
        • Recrutamento
        • UT Southwestern Simmons Cancer Center - RedBird
        • Investigador principal:
          • Raquibul Hannan
        • Contato:
      • Fort Worth, Texas, Estados Unidos, 76104
        • Recrutamento
        • UT Southwestern/Simmons Cancer Center-Fort Worth
        • Contato:
        • Investigador principal:
          • Raquibul Hannan
      • Richardson, Texas, Estados Unidos, 75080
        • Recrutamento
        • UT Southwestern Clinical Center at Richardson/Plano
        • Contato:
        • Investigador principal:
          • Raquibul Hannan
      • Temple, Texas, Estados Unidos, 76508
        • Recrutamento
        • Scott and White Memorial Hospital
        • Contato:
          • Site Public Contact
          • Número de telefone: 254-724-5407
        • Investigador principal:
          • Lucas Wong
    • Vermont
      • Berlin Corners, Vermont, Estados Unidos, 05602
        • Recrutamento
        • Central Vermont Medical Center/National Life Cancer Treatment
        • Investigador principal:
          • Nataniel H. Lester-Coll
        • Contato:
          • Site Public Contact
          • Número de telefone: 802-225-5400
      • Burlington, Vermont, Estados Unidos, 05401
        • Recrutamento
        • University of Vermont Medical Center
        • Investigador principal:
          • Nataniel H. Lester-Coll
        • Contato:
          • Site Public Contact
          • Número de telefone: 802-656-4101
          • E-mail: rpo@uvm.edu
      • Burlington, Vermont, Estados Unidos, 05405
        • Recrutamento
        • University of Vermont and State Agricultural College
        • Investigador principal:
          • Nataniel H. Lester-Coll
        • Contato:
          • Site Public Contact
          • Número de telefone: 802-656-8990
          • E-mail: rpo@uvm.edu
    • Virginia
      • Alexandria, Virginia, Estados Unidos, 22304
        • Recrutamento
        • Inova Alexandria Hospital
        • Contato:
        • Investigador principal:
          • Daniel W. Kim
      • Fairfax, Virginia, Estados Unidos, 22031
        • Recrutamento
        • Inova Schar Cancer Institute
        • Contato:
        • Investigador principal:
          • Daniel W. Kim
      • Fairfax, Virginia, Estados Unidos, 22033
        • Recrutamento
        • Inova Fair Oaks Hospital
        • Contato:
        • Investigador principal:
          • Daniel W. Kim
      • Midlothian, Virginia, Estados Unidos, 23114
        • Recrutamento
        • Bon Secours Saint Francis Medical Center
        • Contato:
        • Investigador principal:
          • Joseph D. Pennington
      • Richmond, Virginia, Estados Unidos, 23235
        • Recrutamento
        • VCU Massey Cancer Center at Stony Point
        • Contato:
        • Investigador principal:
          • Alfredo I. Urdaneta
      • Richmond, Virginia, Estados Unidos, 23230
        • Recrutamento
        • Bon Secours Cancer Institute at Reynolds Crossing
        • Contato:
        • Investigador principal:
          • Joseph D. Pennington
      • Richmond, Virginia, Estados Unidos, 23298
        • Recrutamento
        • VCU Massey Comprehensive Cancer Center
        • Investigador principal:
          • Alfredo I. Urdaneta
        • Contato:
    • Washington
      • Seattle, Washington, Estados Unidos, 98101
        • Recrutamento
        • Virginia Mason Medical Center
        • Investigador principal:
          • Huong T. Pham
        • Contato:
    • West Virginia
      • Charleston, West Virginia, Estados Unidos, 25304
        • Ativo, não recrutando
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Huntington, West Virginia, Estados Unidos, 25701
        • Recrutamento
        • Edwards Comprehensive Cancer Center
        • Contato:
        • Investigador principal:
          • Toni O. Pacioles
    • Wisconsin
      • Antigo, Wisconsin, Estados Unidos, 54409
        • Recrutamento
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
        • Contato:
        • Investigador principal:
          • Andrew J. Huang
      • Ashland, Wisconsin, Estados Unidos, 54806
        • Recrutamento
        • Duluth Clinic Ashland
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Ashland, Wisconsin, Estados Unidos, 54806
        • Recrutamento
        • Northwest Wisconsin Cancer Center
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Eau Claire, Wisconsin, Estados Unidos, 54701
      • Green Bay, Wisconsin, Estados Unidos, 54301
        • Recrutamento
        • Saint Vincent Hospital Cancer Center Green Bay
        • Investigador principal:
          • Matthew L. Ryan
        • Contato:
      • Green Bay, Wisconsin, Estados Unidos, 54303
        • Recrutamento
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Investigador principal:
          • Matthew L. Ryan
        • Contato:
      • Hayward, Wisconsin, Estados Unidos, 54843
        • Recrutamento
        • Essentia Health-Hayward Clinic
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • La Crosse, Wisconsin, Estados Unidos, 54601
        • Recrutamento
        • Gundersen Lutheran Medical Center
        • Contato:
        • Investigador principal:
          • Collin D. Driscoll
      • Ladysmith, Wisconsin, Estados Unidos, 54848
        • Ativo, não recrutando
        • Marshfield Medical Center - Ladysmith
      • Madison, Wisconsin, Estados Unidos, 53792
        • Recrutamento
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Contato:
        • Investigador principal:
          • Amy K. Taylor
      • Madison, Wisconsin, Estados Unidos, 53718
        • Recrutamento
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • Contato:
        • Investigador principal:
          • Amy K. Taylor
      • Marshfield, Wisconsin, Estados Unidos, 54449
      • Menomonee Falls, Wisconsin, Estados Unidos, 53051
        • Recrutamento
        • Froedtert Menomonee Falls Hospital
        • Investigador principal:
          • William A. Hall
        • Contato:
          • Site Public Contact
          • Número de telefone: 262-257-5100
      • Milwaukee, Wisconsin, Estados Unidos, 53226
        • Recrutamento
        • Medical College of Wisconsin
        • Investigador principal:
          • William A. Hall
        • Contato:
          • Site Public Contact
          • Número de telefone: 414-805-3666
      • Minocqua, Wisconsin, Estados Unidos, 54548
      • Mukwonago, Wisconsin, Estados Unidos, 53149
        • Recrutamento
        • ProHealth D N Greenwald Center
        • Contato:
        • Investigador principal:
          • Timothy R. Wassenaar
      • Neillsville, Wisconsin, Estados Unidos, 54456
        • Ativo, não recrutando
        • Marshfield Medical Center - Neillsville
      • New Richmond, Wisconsin, Estados Unidos, 54017
        • Recrutamento
        • Cancer Center of Western Wisconsin
        • Contato:
        • Investigador principal:
          • Charles Shideman
      • Oak Creek, Wisconsin, Estados Unidos, 53154
        • Recrutamento
        • Drexel Town Square Health Center
        • Investigador principal:
          • William A. Hall
        • Contato:
          • Site Public Contact
          • Número de telefone: 414-805-0505
      • Oconomowoc, Wisconsin, Estados Unidos, 53066
        • Recrutamento
        • ProHealth Oconomowoc Memorial Hospital
        • Investigador principal:
          • Timothy R. Wassenaar
        • Contato:
          • Site Public Contact
          • Número de telefone: 262-928-7878
      • Rhinelander, Wisconsin, Estados Unidos, 54501
        • Recrutamento
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
        • Investigador principal:
          • Andrew J. Huang
        • Contato:
      • Rice Lake, Wisconsin, Estados Unidos, 54868
      • Sheboygan, Wisconsin, Estados Unidos, 53081
        • Recrutamento
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Investigador principal:
          • Matthew L. Ryan
        • Contato:
      • Spooner, Wisconsin, Estados Unidos, 54801
        • Recrutamento
        • Essentia Health-Spooner Clinic
        • Contato:
        • Investigador principal:
          • Bret E. Friday
      • Stevens Point, Wisconsin, Estados Unidos, 54482
      • Stevens Point, Wisconsin, Estados Unidos, 54481
        • Recrutamento
        • Aspirus Cancer Care - Stevens Point
        • Investigador principal:
          • Andrew J. Huang
        • Contato:
      • Sturgeon Bay, Wisconsin, Estados Unidos, 54235-1495
        • Recrutamento
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Investigador principal:
          • Matthew L. Ryan
        • Contato:
      • Superior, Wisconsin, Estados Unidos, 54880
        • Recrutamento
        • Essentia Health Saint Mary's Hospital - Superior
        • Investigador principal:
          • Bret E. Friday
        • Contato:
          • Site Public Contact
          • Número de telefone: 701-364-6272
      • Waukesha, Wisconsin, Estados Unidos, 53188
        • Recrutamento
        • UW Cancer Center at ProHealth Care
        • Investigador principal:
          • Timothy R. Wassenaar
        • Contato:
      • Wausau, Wisconsin, Estados Unidos, 54401
        • Recrutamento
        • Aspirus Cancer Care-Wausau
        • Investigador principal:
          • Andrew J. Huang
        • Contato:
          • Site Public Contact
          • Número de telefone: 877-405-6866
      • West Bend, Wisconsin, Estados Unidos, 53095
        • Recrutamento
        • Froedtert West Bend Hospital/Kraemer Cancer Center
        • Investigador principal:
          • William A. Hall
        • Contato:
          • Site Public Contact
          • Número de telefone: 414-805-0505
      • Weston, Wisconsin, Estados Unidos, 54476
      • Wisconsin Rapids, Wisconsin, Estados Unidos, 54494
        • Recrutamento
        • Aspirus Cancer Care - Wisconsin Rapids
        • Investigador principal:
          • Andrew J. Huang
        • Contato:
          • Site Public Contact
          • Número de telefone: 715-422-7718
      • Wisconsin Rapids, Wisconsin, Estados Unidos, 54494
        • Ativo, não recrutando
        • Marshfield Clinic - Wisconsin Rapids Center
    • Co Dublin
      • Dublin, Co Dublin, Irlanda, 18
        • Suspenso
        • Beacon Hospital
      • Dublin, Co Dublin, Irlanda, 6
        • Suspenso
        • Saint Lukes Hospital
    • Co Galway
      • Galway, Co Galway, Irlanda
        • Suspenso
        • University College Hospital Galway

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Pathologically (histologically or cytologically) proven diagnosis of renal cell carcinoma prior to registration

  • Node-positive unresectable (TxN1Mx) or metastatic (TxNxM1) based on the following diagnostic workup:

    • History/physical examination within 45 days prior to registration
    • CT/magnetic resonance imaging (MRI) of the chest/abdomen/pelvis within 45 days prior to registration
  • Patients must have IMDC intermediate (1-2 factors) or poor risk disease (>= 3 factors)

  • Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial

  • Patients with measurable disease (node positive or metastatic) as defined by RECIST version 1.1 excluding the primary renal tumor

  • Patient not recommended for or refused immediate cytoreductive nephrectomy

  • Candidate for standard of care therapy with either immuno-oncology (IO)-IO or IO-VEGF combination regimen

  • Primary renal tumor measuring 20 cm or less in anterior to posterior dimension only on axial imaging

  • Age >= 18

  • Karnofsky performance status >= 60 within 45 days prior to registration

  • Hemoglobin >= 8 g/dL (transfusions are allowed) (within 45 days prior to registration)

  • Platelet count >= 50,000/mm^3 (within 45 days prior to registration)

  • Absolute neutrophil count (ANC) >= 1500/mm^3 (within 45 days prior to registration)

  • Calculated (Calc.) creatinine clearance >= 30 mL/min (within 45 days prior to registration)

    • Creatinine clearance (CrCl) >= 30 mL/min estimated by Cockcroft-Gault Equation
    • For African American patients specifically whose renal function is not considered adequate by the formula above, an alternative formula that takes race into account (Chronic Kidney Disease Epidemiology Collaboration CKD-EPI formula) should be used for calculating the related estimated glomerular filtration rate (GFR) with a correction factor for African American race creatinine clearance for trial eligibility, where GFR >= 30 mL/min/1.73m^2 will be considered adequate
  • Total bilirubin =< 1.5 x upper limit of normal (ULN) (except subjects with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL) (within 45 days prior to registration)

  • Aspartate aminotransferase and alanine aminotransferase (AST and ALT) =< 3 x upper limit of normal (ULN) or < 5 x ULN if hepatic metastases present (within 45 days prior to registration)

  • Patients with known human immunodeficiency virus (HIV) on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial. Testing is not required for entry into protocol

  • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated

  • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. Patients with HCV infection who are currently on treatment are eligible if they have an undetectable HCV viral load

  • The patient must agree to use a highly effective contraception, including men with vasectomies if they are having sex with a woman of childbearing potential or with a woman who is pregnant, while on study drug and for 6 months following the last dose of study drug. Childbearing potential is defined as any person who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal

  • The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information

Exclusion Criteria:

  • Patients with planned treatment of all metastatic disease with definitive therapy including either surgery, ablative (non-palliative) doses of radiation, or intervention of some type (definitive interventional radiology techniques) to ALL metastatic sites rendering the patient without extra-renal measurable disease. Patients NOT planned for definitive treatment of all metastatic sites are eligible. Lesions radiated palliatively are not eligible for response assessment

  • Patients with untreated or unstable brain metastases or cranial epidural disease

    • Note: Patients who have been adequately treated with radiotherapy, radiosurgery, or surgery and stable for at least 4 weeks prior to registration as documented by MRI or CT imaging or deemed stable by clinical investigator are eligible. Treated brain metastases are defined as having no ongoing requirement for steroids and no evidence of progression or hemorrhage after treatment for at least 4 weeks prior to registration as documented by MRI or CT imaging or deemed stable by clinical investigator
  • Prior radiotherapy to the kidney that would result in overlap of radiation therapy fields treatment of the primary tumor

  • Any systemic therapy for metastatic renal cell carcinoma (RCC) that was initiated > 90 days before registration, note that prior chemotherapy for a different cancer is allowed (completed > 3 years prior to registration)

  • Severe, active comorbidity defined as follows:

    • Active autoimmune disease requiring ongoing therapy including systemic treatment with corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications daily. Inhaled steroids and adrenal replacement steroid doses > 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease
    • History of severe allergic, anaphylactic or other hypersensitivity reactions to chimeric or humanized antibodies
    • Active tuberculosis (purified protein derivative [PPD] response without active tuberculosis [TB] is allowed)
    • Uncontrolled hypertension (systolic blood pressure [BP] >= 190 mmHg or diastolic BP > 110 mmHg)
    • Major surgery requiring hospital admission =< 28 days prior to registration
    • Any serious (requiring hospital stay or long term rehab) non-healing wound, ulcer, or bone fracture within 45 days prior to registration
    • Any arterial thrombotic (ST elevation myocardial infarction [STEMI], non-ST elevation myocardial infarction [NSTEMI], cerebrovascular accident [CVA], etc) events within 180 days prior to registration
    • Active New York (NY) Heart Association class 3-4 heart failure symptoms
    • Moderate or severe hepatic impairment (Child-Pugh B or C)
    • Any history of untreated pulmonary embolism or deep venous thrombosis (DVT) within 180 days prior to registration. (Any asymptomatic or treated pulmonary embolism or asymptomatic treated deep venous thrombosis > 30 days prior to registration is allowed)
    • Unstable cardiac arrhythmia within 180 days prior to registration
    • History of abdominal fistula, gastrointestinal perforation, intra-abdominal abscess, bowel obstruction, or gastric outlet obstruction within 180 days prior to registration
    • History of or active inflammatory bowel disease
    • Malabsorption syndrome within 45 days prior to registration
  • Pregnancy and individuals unwilling to discontinue nursing. For women of child bearing potential must have a negative pregnancy test =< 45 days prior to registration

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Arm I (standard of care immunotherapy)

Patients receive one of the following immunotherapy regimens per physician discretion: nivolumab IV over 30 minutes and ipilimumab IV over 30 minutes every 3 weeks for 4 doses followed by nivolumab IV over 30 minutes every 2 or 4 weeks; pembrolizumab IV over 30 minutes every 3 or 6 weeks and axitinib PO BID; avelumab IV over 60 minutes every 2 weeks and axitinib PO BID; nivolumab IV over 30 minutes every 2 or 4 weeks and cabozantinib PO QD; OR pembrolizumab IV over 30 minutes every 3 or 6 weeks and lenvatinib PO QD. Treatment with immunotherapy continues in the absence of disease progression or unacceptable toxicity. Patients also undergo CT scan or MRI throughout the trial. Patients may also undergo a bone scan as clinically indicated and blood sample collection throughout the trial.

Given IV

Outros nomes:
  • Anticorpo Monoclonal Antigen-4 Associado a Linfócitos T Anti-Citotóxicos
  • BMS-734016
  • Ipilimumabe Biossimilar CS1002
  • MDX-010
  • MDX-CTLA4
  • Yervoy
  • MDX010
  • BMS734016
  • BMS 734016
  • MDX 010

Undergo CT

Outros nomes:
  • TC
  • GATO
  • Tomografia
  • Tomografia Axial Computadorizada
  • Tomografia computadorizada
  • tomografia
  • Tomografia axial computadorizada (procedimento)
  • Tomografia computadorizada (TC)
  • Diagnóstico Cat Scan
  • Tipo de serviço de varredura de gato diagnóstico

Undergo MRI

Outros nomes:
  • Ressonância magnética
  • Varredura de imagem por ressonância magnética
  • Imagem Médica, Ressonância Magnética / Ressonância Magnética Nuclear
  • SENHOR
  • Exame de ressonância magnética
  • Imagem NMR
  • Ressonância Magnética Nuclear
  • Ressonância Magnética (MRI)
  • ressonância magnética
  • Ressonância magnética (procedimento)
  • Ressonâncias magnéticas
  • RM estrutural

Undergo collection of blood

Outros nomes:
  • Coleta de Amostras Biológicas
  • Bioespécime coletado
  • Coleta de amostras

Given IV

Outros nomes:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumabe Biossimilar CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumabe Biossimilar ABP 206
  • BCD-263
  • Nivolumabe Biossimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Given IV

Outros nomes:
  • Keytruda
  • MK-3475
  • Lambrolizumabe
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumabe Biossimilar BCD-201
  • Pembrolizumabe Biossimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumabe Biossimilar GME751
  • SCH900475
  • Pembrolizumabe Biossimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab biossimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo bone scan

Outros nomes:
  • Cintilografia Óssea

Given PO

Given IV

Outros nomes:
  • Bavencio
  • MSB-0010718C
  • MSB0010718C

Given PO

Outros nomes:
  • AG-013736
  • AG013736
  • Inlyta
  • AG 013736

Given PO

Outros nomes:
  • E7080
  • ER-203492-00
  • Inibidor Multiquinase E7080
  • E 7080
  • E-7080
Experimental: Arm II (SABR, standard of care immunotherapy)

Patients undergo SABR on 3 different days over 1-3 weeks and receive immunotherapy as in Arm I. Patients also undergo CT scan or MRI throughout the trial. Patients may also undergo a bone scan as clinically indicated and blood sample collection throughout the trial.

Given IV

Outros nomes:
  • Anticorpo Monoclonal Antigen-4 Associado a Linfócitos T Anti-Citotóxicos
  • BMS-734016
  • Ipilimumabe Biossimilar CS1002
  • MDX-010
  • MDX-CTLA4
  • Yervoy
  • MDX010
  • BMS734016
  • BMS 734016
  • MDX 010

Undergo CT

Outros nomes:
  • TC
  • GATO
  • Tomografia
  • Tomografia Axial Computadorizada
  • Tomografia computadorizada
  • tomografia
  • Tomografia axial computadorizada (procedimento)
  • Tomografia computadorizada (TC)
  • Diagnóstico Cat Scan
  • Tipo de serviço de varredura de gato diagnóstico

Undergo MRI

Outros nomes:
  • Ressonância magnética
  • Varredura de imagem por ressonância magnética
  • Imagem Médica, Ressonância Magnética / Ressonância Magnética Nuclear
  • SENHOR
  • Exame de ressonância magnética
  • Imagem NMR
  • Ressonância Magnética Nuclear
  • Ressonância Magnética (MRI)
  • ressonância magnética
  • Ressonância magnética (procedimento)
  • Ressonâncias magnéticas
  • RM estrutural

Undergo collection of blood

Outros nomes:
  • Coleta de Amostras Biológicas
  • Bioespécime coletado
  • Coleta de amostras

Given IV

Outros nomes:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumabe Biossimilar CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumabe Biossimilar ABP 206
  • BCD-263
  • Nivolumabe Biossimilar BCD-263
  • BMS936558
  • ONO 4538
  • ONO4538

Given IV

Outros nomes:
  • Keytruda
  • MK-3475
  • Lambrolizumabe
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumabe Biossimilar BCD-201
  • Pembrolizumabe Biossimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumabe Biossimilar GME751
  • SCH900475
  • Pembrolizumabe Biossimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab biossimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo bone scan

Outros nomes:
  • Cintilografia Óssea

Given PO

Given IV

Outros nomes:
  • Bavencio
  • MSB-0010718C
  • MSB0010718C

Given PO

Outros nomes:
  • AG-013736
  • AG013736
  • Inlyta
  • AG 013736

Given PO

Outros nomes:
  • E7080
  • ER-203492-00
  • Inibidor Multiquinase E7080
  • E 7080
  • E-7080

42 Gy in 3 fractions

Outros nomes:
  • SABRE
  • SABR/SBRT

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Nephrectomy and radiographic progression-free survival (nrPFS)
Prazo: From randomization to last follow-up, up to 8 years

Nephrectomy and radiographic progression-free survival time is defined as time from randomization to the date of first radiographic progression, nephrectomy, death, or last negative evaluation (censored). nrPFS rates are estimated using the Kaplan-Meier method. Progression is determined by the Response Evaluation Criteria in Solid Tumors version 1.1 criteria modified for immunotherapy trials (iRECIST).

From randomization to last follow-up, up to 8 years

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Porcentagem de participantes submetidos a nefrectomia citorredutora
Prazo: Da randomização ao último acompanhamento, até 8 anos
Da randomização ao último acompanhamento, até 8 anos
Percentage of participants with complete or partial response
Prazo: From randomization to disease progression

Best overall response is determined by the iRECIST version 1.1.

From randomization to disease progression
Percentage of participants with complete or partial response in the primary renal mass
Prazo: From randomization to disease progression

Best overall response is determined by the iRECIST version 1.1.

From randomization to disease progression
Radiographic progression-free survival (rPFS)
Prazo: From randomization to last follow-up, up to 8 years

Radiographic progression-free survival time is defined as time from randomization to the date of first radiographic progression, death, or last negative evaluation (censored). rPFS rates are estimated using the Kaplan-Meier method. Radiographic progression is determined by the iRECIST version 1.1.

From randomization to last follow-up, up to 8 years
Nephrectomy and radiographic progression-free survival excluding nephrectomies that were performed for non-protocol specified reasons (nrPFS2)
Prazo: From randomization to last follow-up, up to 8 years

Nephrectomy and radiographic progression-free survival time (excluding nephrectomies that were performed for non-protocol specified reasons) is defined as time from randomization to the date of first radiographic progression, nephrectomy performed for protocol-stated reasons, death, or last negative evaluation (censored). nrPFS2 rates are estimated using the Kaplan-Meier method. Progression is determined by the iRECIST version 1.1.

From randomization to last follow-up, up to 8 years
Overall survival
Prazo: From randomization to last follow-up, up to 8 years

Overall survival time is defined as time from randomization to the date of death or last known follow-up (censored). Overall survival rates are estimated by the Kaplan-Meier method.

From randomization to last follow-up, up to 8 years
Second-line therapy-free survival
Prazo: From randomization to last follow-up, up to 8 years

Second-line therapy-free survival time is defined as time from randomization to the date of the initiation of second-line therapy, death, or last known follow-up (censored). Second-line therapy-free survival rates are estimated using the Kaplan-Meier method.

From randomization to last follow-up, up to 8 years
Treatment-free survival
Prazo: From randomization to last follow-up, up to 8 years

Treatment-free survival time is defined as time from the discontinuation of protocol therapy to the date of death or last follow-up (censored). Treatment-free survival rates are estimated using the Kaplan-Meier method.

From randomization to last follow-up, up to 8 years
Percentage of participants with adverse events
Prazo: From randomization to last follow-up, up to 8 years

Common Terminology Criteria for Adverse Events 5.0 grades adverse event severity from 1=mild to 5=death.

From randomization to last follow-up, up to 8 years

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
nrPFS and overall survival
Prazo: From randomization to last follow-up, up to 8 years

Exploratory analyses will compare nrPFS and overall survival in four pre-defined subgroups: clear cell versus (vs.) non-clear cell histology, intermediate vs. poor International Metastatic RCC database consortium risk group, treatment with immuno-oncology (IO)-IO vs. IO-vascular endothelial growth factor, and sarcomatoid vs. non sarcomatoid variant. Forest plots will be constructed showing estimated hazard ratios from Cox models and 90% confidence intervals generated within each subgroup. Treatment-by-subgroup interaction terms will be incorporated into the Cox modelling to assess whether the effect of stereotactic ablative radiotherapy (SABR) varies significantly by subgroup; however, these analyses will be considered hypothesis-generating only.

From randomization to last follow-up, up to 8 years
Prognostic and predictive biomarkers
Prazo: From randomization to last follow-up, up to 8 years

Will be accomplished by including the biomarkers in Cox time-to-event regression models for the evaluation of prognostic factors. Treatment-by-biomarker interaction terms will be incorporated into the modelling process to assess for potential predictive markers.

From randomization to last follow-up, up to 8 years
Abscopal effect of SABR with systemic therapy
Prazo: From randomization to disease progression

These analyses will include only patients in the control arm who have not received any palliative radiation therapy and those in the experimental arm who have received protocol defined stereotactic body radiation therapy only without additional radiation therapy. Response rates among lesions outside the renal mass will be determined based in iRECIST criteria and compared using a chi-square test.

From randomization to disease progression
Impact of treatment on the level of inferior vena cava (IVC) thrombus
Prazo: From randomization to last follow-up, up to 8 years

Will be assessed by comparing the rates of IVC thromboembolism using Fisher's exact test. Cumulative incidence curves with death as a competing risk will also be generated and compared using the Fine-Gray test.

From randomization to last follow-up, up to 8 years
Accuracy of accruing center radiologist defined progression as compared with central radiology defined progression
Prazo: From randomization to last follow-up, up to 8 years

This will take place at the conclusion of the trial by our diagnostic radiologists. Will determine the number and proportion of center radiologist defined progressions (confirmed per iRECIST) that are validated/not validated upon central review. Will also examine all center radiologist defined pseudo progressions (i.e., not confirmed per iRECIST) and determine the number that are also declared pseudo progressions upon central review.

From randomization to last follow-up, up to 8 years

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: William A Hall, NRG Oncology

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de fevereiro de 2023

Conclusão Primária (Estimado)

15 de junho de 2028

Conclusão do estudo (Estimado)

15 de junho de 2033

Datas de inscrição no estudo

Enviado pela primeira vez

7 de abril de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

7 de abril de 2022

Primeira postagem (Real)

14 de abril de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

23 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

21 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • NRG-GU012
  • U10CA180868 (Concessão/Contrato do NIH dos EUA)
  • NRG-GU012 (Outro identificador: CTEP)
  • NCI-2022-02189 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
  • NRG-GU012 (Outro identificador: NRG Oncology)

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Sim

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .